MedPath

Comparing the effects of mass drug administration using Praziquantel drug with and without diagnosis on treatment compliance

Not Applicable
Recruiting
Conditions
Digestive System
intestinal schistosomiasis
Registration Number
PACTR201804003343404
Lead Sponsor
Catholic University of Health and Allied Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5000
Inclusion Criteria

(i) aged 18 years and above
(ii) willing to participate and give written informed consent
(iii) Living in the study area

Exclusion Criteria

i) Pregnant at the time of treatment
(ii) history of adverse reaction to praziquantel
(iii) Present with serious conditions at the time of treatment and not deemed fit to take treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the proportion of study participants provided with praziquantel drug (treatment coverage) and geographical cluster (a service area of the community health workers) in the intervention and control arms
Secondary Outcome Measures
NameTimeMethod
Community Health Workers (CHWs) ability to use POC-CCA rapid test accurately and safely;Community members acceptability (these are people¿s perceptions and attitude on the two-treatment approach) of POC-CCA test results offered by community health workers;Experience of Community Health Workers on the use of POC-CCA rapid diagnostic test
© Copyright 2025. All Rights Reserved by MedPath